Korean Company Supplies 93% of Global Cholera Vaccine Stockpile, WHO Says

A Korean company supplies 93% of the global cholera vaccine stockpile, according to World Health Organization Director-General Dr. Tedros Adhanom Ghebreyesus.

In a new statement, Tedros said annual production of oral cholera vaccines is rising from 30 million doses in 2022 to 80 million doses in 2025.

The figures point to a substantial expansion in vaccine production over that period, with annual output set to more than double.

At the same time, the Korean company’s share of the global stockpile highlights the central role of a single supplier. The production increase and the concentration of supply are key features of the vaccine picture outlined by the WHO chief.